An interview with Mr. Rani Hagag, Vice President, Aesthetic Business Group of Lumenis Ltd., the global leader in the field of energy-based medical solutions for Aesthetic, Surgical and Eye Care applications.



Can you tell us briefly your company’s success story and which beauty sectors it serves?

Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmic and Aesthetic markets. The company has a rich legacy of over 50-years, commercializing numerous breakthrough energy-based medical technologies, including Laser, Intense Pulsed Light (IPL), CO2 laser and Radio-Frequency (RF). In the Aesthetic space, Lumenis serves medical aesthetics practices, beauty salons as well as the home-use device market.


How do you see the medical aesthetic markets in Asia? What are the biggest challenges that you were facing?

The medical aesthetic markets in Asia is one of the fastest changing markets in the industry. Over recent years, focus has shifted from the face, to the body and most recently to muscle – it is truly changing every day. Quick adoption of these various technologies and quick shifts in consumer interest are the biggest challenges that we all are facing right now.


What makes your company’s products and services unique?

As mentioned, Lumenis is the global pioneer of laser technology and energy-based medical devices. In all divisions, Lumenis prides itself on providing Better Technology for Better Patient Care – offering our customers premium technologies that deliver proven, superior clinical outcomes to patients. For example, PiQo4: a four-wavelength platform, which treats a wide range of pigment colors and offers a versatile energy matrix ensuring effective shattering of pigment deposits. It also has the largest spot size on the market, which allows you to deliver faster treatments. PiQo4’s ability to treat a wide variety of skin conditions, including tattoo removal, provides your customers an attractive range of aesthetic solutions to improve their lifestyle and sense of well-being.

PiQo4 by LUMENIS (Booth no. 3E-J3A)


Which are the key markets in Asia Pacific? Who are the potential customers?

Our APAC operations span numerous countries across the region, including our direct presence China, which was opened nearly 30 years ago.

Key markets for Lumenis in Asia Pacific include Hong Kong, Taiwan, China, Japan, Korea, Australis and India, etc. Our tradition customers are medical aesthetics clinics and beauty salons.


What are the benefits of exhibiting at Cosmoprof Asia?

Exhibiting at Cosmoprof Asia allows visitors from across the world to get to know our products and also to experience the treatments on-site…getting a first-hand feel of what Lumenis is all about!


What are the next step of company development?

Lumenis is committed to growth…and more specifically to double-digit growth! To achieve this goal, we are committed to further developing and deepening our presence in the existing domains, while continuing to explore and add new domains to our business, as we have done over the past few years. All of this, while never compromising on our commitment to innovation and to our customers, delivering Better Technology for Better Patient Care!



About Lumenis

Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis’ ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards.  For more information visit:



Discover more by visiting Cosmoprof Asia 2019 from 12 to 14 November 2019 at AsiaWorld-Expo (AWE), and from 13 to 15 November 2019 at the Hong Kong Convention & Exhibition Centre (HKCEC). Check out Who’s Exhibiting this year! Register now to secure your entry to the fair!



Leave a Reply

Your email address will not be published. Required fields are marked *